Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00962494
Other study ID # VAR0044
Secondary ID SU-07292009-3460
Status Completed
Phase Phase 2
First received August 18, 2009
Last updated February 5, 2013
Start date July 2009
Est. completion date December 2011

Study information

Verified date February 2013
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality of life.


Description:

This workshop is aimed at helping you better manage your own health and the demands placed on you because of your cancer diagnosis. It is hoped that the workshop will give you the skills needed to reduce stress and improve your quality of life. If successful, the workshop can be made available to other cancer survivors.

Each workshop is 6 weeks with new lessons each week. You will be asked to log on at your convenience 2-3 times each week for a total of 1-2 hours, to read the lessons, complete assignments, and share your ideas and experiences with your classmates. There are no requirements that participants log in at the same time.

With the moderators and other workshop participants, you will discuss:

- Healthy eating

- Managing fatigue

- Managing stress

- Starting and maintaining an appropriate physical activity program

- Getting a good night's sleep

- Dealing with difficult emotions

- Solving the problems caused by having had cancer

- Communicating better with your health care professionals

- Communicating better with your friends, family and coworkers


Recruitment information / eligibility

Status Completed
Enrollment 585
Est. completion date December 2011
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria:Any adult (19 and over) cancer survivor living in the United States who: 1) was diagnosed within the past 5 years with a new or recurring cancer since the original diagnosis; 2) has completed their cancer treatment (surgery, radiation and/or chemotherapy); 3) isn't currently being treated for cancer except for hormonal therapy; and 4) has and email account and access to high speed internet connection.

Exclusion Criteria:Not meeting the inclusion criteria

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Behavioral:
Cancer: Thriving and Surviving Online Workshop


Locations

Country Name City State
United Kingdom Macmillan Cancer Support London UK
United States Stanford University School of Medicine Stanford California

Sponsors (2)

Lead Sponsor Collaborator
Stanford University University of Hawaii Cancer Research Center

Countries where clinical trial is conducted

United States,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Document patterns of health care utilization 2011 No
Primary Quality of Life baseline and 6 months No
Primary Outcome Measure: Better Interactions with Oncologists baseline and 6 months No
Primary Health Behaviors baseline and 6 months No
Secondary Satisfaction with intervention baseline and 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A